Funder
Bill & Melinda Gates Foundation
Eli Lilly and Company
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference15 articles.
1. WHO, Global Tuberculosis Report 2015, Geneva, 2015.
2. Synthesis and SAR of [1,2,4]triazolo[1,5-a]pyrimidines, a class of anticancer agents with a unique mechanism of tubulin inhibition;Zhang;J Med Chem,2007
3. Discovery of triazolopyrimidine-based PDE8B inhibitors: exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes;DeNinno;Bioorg Med Chem Lett,2012
4. Essramycin: a first triazolopyrimidine antibiotic isolated from nature;El-Gendy;J Antibiot (Tokyo),2008
5. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice;Gujjar;J Med Chem,2009
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献